Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125403131 | 12540313 | 1 | I | 2013 | 20150818 | 20160708 | 20160708 | EXP | US-DSJP-DSU-2015-125980 | DAIICHI | 45.58 | YR | F | Y | 122.45000 | KG | 20160708 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125403131 | 12540313 | 1 | PS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/25 MG | N | 21532 | FILM-COATED TABLET | |||||||||
| 125403131 | 12540313 | 2 | C | IBUPROFEN. | IBUPROFEN | 1 | UNK | 0 | |||||||||||
| 125403131 | 12540313 | 3 | C | NAPROXEN. | NAPROXEN | 1 | UNK | 0 | |||||||||||
| 125403131 | 12540313 | 4 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | UNK | 0 | |||||||||||
| 125403131 | 12540313 | 5 | C | MELOXICAM. | MELOXICAM | 1 | UNK | 0 | |||||||||||
| 125403131 | 12540313 | 6 | C | KETOROLAC | KETOROLACKETOROLAC TROMETHAMINE | 1 | UNK | 0 | |||||||||||
| 125403131 | 12540313 | 7 | C | LORTAB | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125403131 | 12540313 | 1 | Hypertension |
| 125403131 | 12540313 | 2 | Product used for unknown indication |
| 125403131 | 12540313 | 3 | Product used for unknown indication |
| 125403131 | 12540313 | 4 | Product used for unknown indication |
| 125403131 | 12540313 | 5 | Product used for unknown indication |
| 125403131 | 12540313 | 6 | Product used for unknown indication |
| 125403131 | 12540313 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125403131 | 12540313 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125403131 | 12540313 | Anxiety | |
| 125403131 | 12540313 | Constipation | |
| 125403131 | 12540313 | Depression | |
| 125403131 | 12540313 | Dyspepsia | |
| 125403131 | 12540313 | Gastrooesophageal reflux disease | |
| 125403131 | 12540313 | Malabsorption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125403131 | 12540313 | 1 | 201004 | 201503 | 0 | |
| 125403131 | 12540313 | 2 | 2013 | 0 | ||
| 125403131 | 12540313 | 3 | 2011 | 0 | ||
| 125403131 | 12540313 | 4 | 201004 | 0 | ||
| 125403131 | 12540313 | 5 | 201306 | 0 | ||
| 125403131 | 12540313 | 6 | 201306 | 0 | ||
| 125403131 | 12540313 | 7 | 201306 | 0 |